54 results on '"Aroldi, A"'
Search Results
2. Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience
3. Performance evaluation of the SIMBIO-SYS Stereo Imaging Channel on board BepiColombo/ESA spacecraft
4. 1093TiP An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE]
5. 549P Results of a first-in-human study of the ProTide thymidylate synthase inhibitor NUC-3373, in patients with advanced solid tumours (NuTide:301)
6. 566TiP A first-in-human study of NUC-7738, a ProTide transformation of 3’-deoxyadenosine, in patients with advanced solid tumours (NuTide:701)
7. 1093TiP An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE]
8. 566TiP A first-in-human study of NUC-7738, a ProTide transformation of 3’-deoxyadenosine, in patients with advanced solid tumours (NuTide:701)
9. Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies
10. Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
11. 600TiP A first-in-human study of, NUC-7738, a 3'-dA phosphoramidate, in patients with advanced solid tumours (NuTide:701)
12. 464P Pharmacokinetic analysis of NUC-3373 with and without leucovorin in patients with previously treated metastatic colorectal cancer (NuTide:302 study)
13. 549P Results of a first-in-human study of the ProTide thymidylate synthase inhibitor NUC-3373, in patients with advanced solid tumours (NuTide:301)
14. 464P Pharmacokinetic analysis of NUC-3373 with and without leucovorin in patients with previously treated metastatic colorectal cancer (NuTide:302 study)
15. 600TiP A first-in-human study of, NUC-7738, a 3'-dA phosphoramidate, in patients with advanced solid tumours (NuTide:701)
16. Performance evaluation of the SIMBIO-SYS Stereo Imaging Channel on board BepiColombo/ESA spacecraft
17. Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
18. Hair loss prevention by scalp cooling device in early breast cancer patients: the Poliambulanza experience
19. Dignity Therapy: a new psychoterapeutic approach for people facing advanced disease
20. Dignity Therapy: a new psychoterapeutic approach for people facing advanced disease
21. Hair loss prevention by scalp cooling device in early breast cancer patients: the Poliambulanza experience
22. Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRIME-NET (Pancreatic multicentric, Retrospective, Italian MEtformin) study
23. Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRIME-NET (Pancreatic multicentric, Retrospective, Italian MEtformin) study
24. Hypertension After Renal Transplantation
25. “Yoga project in Oncology: observational study of the Yoga effects in cancer patient. The Poliambulanza experience”
26. Chemotherapy rechallenge after regorafenib treatment in metastatic colorectal cancer. Still hope after the last hope?
27. Chemotherapy rechallenge after regorafenib treatment in metastatic colorectal cancer. Still hope after the last hope?
28. 'Yoga project in Oncology: observational study of the Yoga effects in cancer patient. The Poliambulanza experience'
29. Long-term evolution of anti–HCV-positive renal transplant recipients
30. Who Should Receive First-Line Folfirinox? Prognostic Factors in Locally Advanced or Metastatic Pancreatic Cancer Patients
31. Single-Agent or Doublets As Second-Line Chemotherapy After Folfirinox in Patients with Locally Advanced or Metastatic Pancreatic Cancer
32. Single-Agent or Doublets As Second-Line Chemotherapy After Folfirinox in Patients with Locally Advanced or Metastatic Pancreatic Cancer
33. Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine
34. Long-term effects of single versus double CsA dosing in kidney transplantation
35. Natural History of Hepatitis C Virus Infection in Adult Renal Graft Recipients
36. From cyclosporine to the future
37. Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine
38. Long-term effects of single versus double CsA dosing in kidney transplantation
39. Renal transplantation from older donors
40. High prevalence, low pathogenicity in hepatitis G virus in kidney transplant recipients
41. Osteoporosis after organ transplantation
42. Long-term evolution of anti–HCV-positive renal transplant recipients
43. F217 Bone loss in postmenopausal women after renal transplantation: HRT versus calcitriol treatment
44. Increased detection of antibody to hepatitis C virus in renal transplant patients by third-generation assays
45. The natural history of hepatitis C in renal allograft recipients: A 5-year prospective study in 443 patients
46. Hypertension After Renal Transplantation
47. F217 Bone loss in postmenopausal women after renal transplantation: HRT versus calcitriol treatment
48. The natural history of hepatitis C in renal allograft recipients: A 5-year prospective study in 443 patients
49. DO THIAZIDES PREVENT RECURRENT IDIOPATHIC RENAL CALCIUM STONES
50. Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.